SYN - Synovus slips 1.5% as Q4 EPS disappoints January, 24 2020 08:47 AM Synthetic Biologics Inc. Synovus Financial (NYSEMKT:SYN) falls 1.5% in premarket trading after Q4 adjusted EPS of 94 cents trails the consensus estimate of 97 cents.More news on: Synthetic Biologics, Inc., Financial stocks news, Earnings news and commentary, , Stocks on the move, , Read more ...